A randomized controlled trial of single-class maintenance therapy with abacavir/lamivudine/zidovudine after standard triple antiretroviral induction therapy: final 96-week results from the FREE study

HG Sprenger; N Langebeek; PGH (Paul) Mulder; CHH Ten Napel; R Vriesendorp; AIM Hoepelman; JC Legrand; PP Koopmans; B Bravenboer; RW Ten Kate; PHP Groeneveld; WFW Bierman; TS Van der Werf; EH Gisolf; C Richter

doi:10.1111/hiv.12186

A randomized controlled trial of single-class maintenance therapy with abacavir/lamivudine/zidovudine after standard triple antiretroviral induction therapy: final 96-week results from the FREE study

HG Sprenger, N Langebeek, PGH (Paul) Mulder, CHH Ten Napel, R Vriesendorp, AIM Hoepelman, JC Legrand, PP Koopmans, B Bravenboer, RW Ten Kate, PHP Groeneveld, WFW Bierman, TS Van der Werf, EH Gisolf, C Richter

Epidemiology

Research output: Contribution to journal › Article › Academic

4 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	122-131
Number of pages	10
Journal	HIV Medicine
Volume	16
Issue number	2
DOIs	https://doi.org/10.1111/hiv.12186
Publication status	Published - 2015

Research programs

EMC NIHES-01-66-01

Access to Document

10.1111/hiv.12186

http://hdl.handle.net/1765/84935

Cite this

Sprenger, HG., Langebeek, N., Mulder, PGH., Ten Napel, CHH., Vriesendorp, R., Hoepelman, AIM., Legrand, JC., Koopmans, PP., Bravenboer, B., Ten Kate, RW., Groeneveld, PHP., Bierman, WFW., Van der Werf, TS., Gisolf, EH., & Richter, C. (2015). A randomized controlled trial of single-class maintenance therapy with abacavir/lamivudine/zidovudine after standard triple antiretroviral induction therapy: final 96-week results from the FREE study. HIV Medicine, 16(2), 122-131. https://doi.org/10.1111/hiv.12186

@article{7c39a57ebc9d47b381e0ab2b7178481c,

title = "A randomized controlled trial of single-class maintenance therapy with abacavir/lamivudine/zidovudine after standard triple antiretroviral induction therapy: final 96-week results from the FREE study",

author = "HG Sprenger and N Langebeek and Mulder, \{PGH (Paul)\} and \{Ten Napel\}, CHH and R Vriesendorp and AIM Hoepelman and JC Legrand and PP Koopmans and B Bravenboer and \{Ten Kate\}, RW and PHP Groeneveld and WFW Bierman and \{Van der Werf\}, TS and EH Gisolf and C Richter",

year = "2015",

doi = "10.1111/hiv.12186",

language = "Undefined/Unknown",

volume = "16",

pages = "122--131",

journal = "HIV Medicine",

issn = "1464-2662",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "2",

}

Sprenger, HG, Langebeek, N, Mulder, PGH, Ten Napel, CHH, Vriesendorp, R, Hoepelman, AIM, Legrand, JC, Koopmans, PP, Bravenboer, B, Ten Kate, RW, Groeneveld, PHP, Bierman, WFW, Van der Werf, TS, Gisolf, EH & Richter, C 2015, 'A randomized controlled trial of single-class maintenance therapy with abacavir/lamivudine/zidovudine after standard triple antiretroviral induction therapy: final 96-week results from the FREE study', HIV Medicine, vol. 16, no. 2, pp. 122-131. https://doi.org/10.1111/hiv.12186

A randomized controlled trial of single-class maintenance therapy with abacavir/lamivudine/zidovudine after standard triple antiretroviral induction therapy: final 96-week results from the FREE study. / Sprenger, HG; Langebeek, N; Mulder, PGH (Paul) et al.
In: HIV Medicine, Vol. 16, No. 2, 2015, p. 122-131.

Research output: Contribution to journal › Article › Academic

TY - JOUR

T1 - A randomized controlled trial of single-class maintenance therapy with abacavir/lamivudine/zidovudine after standard triple antiretroviral induction therapy: final 96-week results from the FREE study

AU - Sprenger, HG

AU - Langebeek, N

AU - Mulder, PGH (Paul)

AU - Ten Napel, CHH

AU - Vriesendorp, R

AU - Hoepelman, AIM

AU - Legrand, JC

AU - Koopmans, PP

AU - Bravenboer, B

AU - Ten Kate, RW

AU - Groeneveld, PHP

AU - Bierman, WFW

AU - Van der Werf, TS

AU - Gisolf, EH

AU - Richter, C

PY - 2015

Y1 - 2015

U2 - 10.1111/hiv.12186

DO - 10.1111/hiv.12186

M3 - Article

C2 - 25472825

SN - 1464-2662

VL - 16

SP - 122

EP - 131

JO - HIV Medicine

JF - HIV Medicine

IS - 2

ER -